| Robert Gr Lang, MD | |
|
3525 Ensign Rd Ne Ste J, Olympia, WA 98506-5065 | |
| (360) 491-0459 | |
| (360) 491-5370 |
| Full Name | Robert Gr Lang |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 52 Years |
| Location | 3525 Ensign Rd Ne Ste J, Olympia, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427127455 | NPI | - | NPPES |
| 1818905 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD00019502 (Washington) | Primary |
| Entity Name | Robert G R Lang Md Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447329412 PECOS PAC ID: 4981594538 Enrollment ID: O20040317000881 |
News Archive
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease.
Thomson ISI has announced that Nano Research, an English-language journal jointly published by Springer and Tsinghua University Press, is now listed in the Science Citation Index-Expanded (SCI-E). The academic journal, founded in July 2008, has been covered in the index from Volume 1, Issue 1. Nano Research is part of Springer's Chinese Library of Science, a collection comprising more than 90 journals.
A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.
Underground drinking water sources in parts of the U.S. and three Asian countries may not be as safe as previously thought due to high levels of manganese, especially at shallow depths, according to a study led by a researcher at the University of California, Riverside.
BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Gr Lang, MD 3525 Ensign Rd Ne Ste J, Olympia, WA 98506-5065 Ph: (360) 491-0459 | Robert Gr Lang, MD 3525 Ensign Rd Ne Ste J, Olympia, WA 98506-5065 Ph: (360) 491-0459 |
News Archive
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease.
Thomson ISI has announced that Nano Research, an English-language journal jointly published by Springer and Tsinghua University Press, is now listed in the Science Citation Index-Expanded (SCI-E). The academic journal, founded in July 2008, has been covered in the index from Volume 1, Issue 1. Nano Research is part of Springer's Chinese Library of Science, a collection comprising more than 90 journals.
A large European research consortium headed by the University of Twente is to receive grants of more than five million euros, predominantly from the EU, to develop a new imaging device for the diagnosis of breast cancer.
Underground drinking water sources in parts of the U.S. and three Asian countries may not be as safe as previously thought due to high levels of manganese, especially at shallow depths, according to a study led by a researcher at the University of California, Riverside.
BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.
› Verified 8 days ago
Yoshihiro Yamamoto, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne, Ste. 100, Olympia, WA 98506 Phone: 360-491-4211 Fax: 360-493-0407 | |
Dr. Sheila M Smitherman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne Ste 200, Pmg Sw Wa Neurosurgery, Olympia, WA 98506 Phone: 360-486-6150 Fax: 360-486-6155 | |
William Frank Emmons Jr., MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 8607 Fernwood St Ne, Olympia, WA 98516 Phone: 360-491-0327 | |
Dr. Ryan Jeremiah Halpin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Brian A Iuliano, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3909 9th Ave Sw, Olympia, WA 98502 Phone: 360-570-3460 Fax: 360-339-7266 | |
Dr. Abhineet Chowdhary, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw Ste A, Olympia, WA 98502 Phone: 360-570-3460 Fax: 360-786-9010 |